[Changes in the plasma amino acid profile in critically ill patients during total parenteral therapy].
The aim of this study was to evaluate the kinetics of arterial plasma amino acid profile during the first 48 h of clinical TPN in order to assess the time necessary to reach the steady-state condition during infusion. Each patient was treated with one of three different amino acid solutions yielding, in the same nitrogen intake, different intakes of individual amino acids. We found four different kinetics for the administered amino acids: an increase of plasma levels immediately after the start of the TPN with no variations during the steady period; the same trend with the steady-state obtained after 6-24 h of TPN infusion; no influence at all; a decrease of fasting plasma levels with the steady-state attained variably during the study period. Each given amino acid showed a different trend partly depending on the supply, suggesting that the steady-state was reached sooner for most amino acids, when the supply was larger. With lower intakes, plasma levels were unaffected or decreased. We conclude that in critically ill patients at least 24 h are needed to obtain stable arterial plasma amino acid concentration during TPN with adequate intakes of amino acid. Knowledge offers the possibility for a quick and accurate assessment of the adequacy of a given preparation (tailored for critically ill patients), it reduces the time span of the study and, as a consequence, the influence of varied metabolic conditions.
Iapichino
G
G
Reparto di Rianimazione E. Vecla, Istituto di Anestesia e Rianimazione, IRCCS, Ospedale Maggiore, Milano.
Radrizzani
D
D
Pasetti
G
G
Colombo
A
A
Grugni
L
L
Guarnerio
C
C
Palandi
A
A
Ronzoni
G
G
Savioli
M
M
Veschi
G
G
D000293:Adolescent; D000328:Adult; D000596:Amino Acids / Q000008:administration & dosage / Q000097:blood*; D016638:Critical Illness; D005260:Female; D006706:Homeostasis; D006801:Humans; D008297:Male; D008875:Middle Aged; D010289:Parenteral Nutrition, Total
D000596:Amino Acids
Variazioni del profilo aminoacidico plasmatico in pazienti critici durante terapia parenterale totale.